Nuveen LLC Makes New Investment in DocGo Inc. $DCGO

Key Points

• Nuveen LLC has acquired 245,845 shares of DocGo Inc. valued at approximately $649,000, constituting 0.24% of the company's stock as of its latest SEC filing.
• DocGo's stock has fluctuated between a 52-week low of $1.23 and a high of $5.68, with a current market cap of $151.61 million.
• Research analysts have mixed opinions on the stock, with a consensus rating of "Moderate Buy" and an average price target of $3.59.

Nuveen LLC acquired a new stake in shares of DocGo Inc. (NASDAQ:DCGO - Free Report) in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor acquired 245,845 shares of the company's stock, valued at approximately $649,000. Nuveen LLC owned about 0.24% of DocGo as of its most recent SEC filing.

Other hedge funds and other institutional investors have also made changes to their positions in the company. MetLife Investment Management LLC lifted its holdings in shares of DocGo by 12.1% in the 4th quarter. MetLife Investment Management LLC now owns 60,245 shares of the company's stock valued at $255,000 after acquiring an additional 6,517 shares during the last quarter. ProShare Advisors LLC lifted its holdings in shares of DocGo by 49.0% in the 4th quarter. ProShare Advisors LLC now owns 28,641 shares of the company's stock valued at $121,000 after acquiring an additional 9,425 shares during the last quarter. Graham Capital Management L.P. lifted its holdings in shares of DocGo by 15.6% in the 4th quarter. Graham Capital Management L.P. now owns 71,407 shares of the company's stock valued at $303,000 after acquiring an additional 9,624 shares during the last quarter. Wells Fargo & Company MN lifted its holdings in shares of DocGo by 31.0% in the 4th quarter. Wells Fargo & Company MN now owns 57,463 shares of the company's stock valued at $244,000 after acquiring an additional 13,584 shares during the last quarter. Finally, Isthmus Partners LLC lifted its holdings in shares of DocGo by 2.3% in the 1st quarter. Isthmus Partners LLC now owns 638,400 shares of the company's stock valued at $1,685,000 after acquiring an additional 14,472 shares during the last quarter. Institutional investors own 56.44% of the company's stock.

Analysts Set New Price Targets

Separately, Canaccord Genuity Group increased their price target on shares of DocGo from $1.45 to $1.60 and gave the company a "hold" rating in a report on Thursday, August 21st. Three analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus price target of $3.59.

DocGo Stock Performance

NASDAQ DCGO traded up $0.02 during trading on Tuesday, hitting $1.59. The stock had a trading volume of 54,684 shares, compared to its average volume of 814,545. The stock has a market capitalization of $155.03 million, a price-to-earnings ratio of -8.34 and a beta of 0.97. The stock has a 50 day simple moving average of $1.53 and a 200 day simple moving average of $1.97. DocGo Inc. has a one year low of $1.23 and a one year high of $5.68.

DocGo (NASDAQ:DCGO - Get Free Report) last issued its earnings results on Thursday, August 7th. The company reported ($0.11) EPS for the quarter, missing analysts' consensus estimates of ($0.06) by ($0.05). The company had revenue of $80.42 million for the quarter, compared to analysts' expectations of $77.58 million. DocGo had a negative return on equity of 3.26% and a negative net margin of 4.20%. DocGo has set its FY 2025 guidance at EPS. On average, sell-side analysts predict that DocGo Inc. will post 0.25 EPS for the current year.

DocGo Profile

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.